Table: Sawai Pharmaceutical - 6-MTH group results
Nov 13 (Reuters)-
Sawai Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2017 Sep 30, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 70.76 65.42
(+8.2 pct) (+11.0 pct)
Operating 11.14 11.36
(-1.9 pct) (-2.1 pct)
Recurring 11.80 11.33
(+4.2 pct) (-1.0 pct)
Net 8.79 8.57
(+2.6 pct) (+0.8 pct)
EPS 238.45 yen 232.33 yen
EPS Diluted 238.30 yen 232.20 yen
Ann Div 130.00 yen 130.00 yen
-Q2 div 65.00 yen 65.00 yen
-Q4 div 65.00 yen 65.00 yen
NOTE - Sawai Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on SAWAI group
See all newsTable: Sawai Group Holdings -Q1 group results (IFRS)
Table: Sawai Group Holdings -2025/26 group results (IFRS)
Brief: Silchester International Cuts Stake In Sawai Group Holdings To 5.82% From 6.83%, Regulatory Filing Shows
Table: Sawai Group Holdings -9-MTH group results (IFRS)
Table: Sawai Group Holdings 6-MTH group results (IFRS)